Maximilian Kopp
Impact in
-
- Diabetes Treatment and Management
-
- Advanced Glycation End Products research
Papers in
-
- Receptor Mechanisms and Signaling 2
- Enzyme function and inhibition 1
-
- Nitric Oxide and Endothelin Effects 3
- Co-authors
- Thomas Münzel (6 shared papers)Andreas Daiber (6 shared papers)Swenja Kröller‐Schön (5 shared papers)Sebastian Steven (5 shared papers)Matthias Oelze (6 shared papers)F. Ravandi Kashani (3 shared papers)Philip Wenzel (3 shared papers)Siyer Roohani (3 shared papers)
In The Last Decade
Maximilian Kopp
8 papers receiving 419 citations
Peers
Comparison fields: 5 of 67
- Endocrinology, Diabetes and Metabolism 199
- Clinical Biochemistry 26
- Physiology 80
- Cardiology and Cardiovascular Medicine 57
- Surgery 99
Countries citing papers authored by Maximilian Kopp
This map shows the geographic impact of Maximilian Kopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian Kopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian Kopp more than expected).
Fields of papers citing papers by Maximilian Kopp
This network shows the impact of papers produced by Maximilian Kopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian Kopp. The network helps show where Maximilian Kopp may publish in the future.
Co-authors
The 25 scholars most cited alongside Maximilian Kopp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 249 | |
| 2 | 2016 | 87 | |
| 3 | 1989 | 46 | |
| 4 | 2015 | 28 | |
| 5 | 2015 | 7 | |
| 6 | 2017 | 6 | |
| 7 | 2019 | 6 | |
| 8 | 2017 | 1 |
About Maximilian Kopp
Maximilian Kopp is a scholar working on Molecular Biology, Physiology, Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Surgery, having authored 8 papers that have together received 430 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (3 papers), Receptor Mechanisms and Signaling (2 papers), Diabetes Treatment and Management (2 papers), Cardiac Imaging and Diagnostics (2 papers), Enzyme function and inhibition (1 paper), Ocular and Laser Science Research (1 paper), Laser-induced spectroscopy and plasma (1 paper) and Advanced Glycation End Products research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (199 citations), Clinical Biochemistry (26 citations), Physiology (80 citations), Cardiology and Cardiovascular Medicine (57 citations) and Surgery (99 citations). Maximilian Kopp has collaborated with scholars based in Germany, France and Austria. Frequent co-authors include Thomas Münzel, Andreas Daiber, Swenja Kröller‐Schön, Sebastian Steven, Matthias Oelze, F. Ravandi Kashani, Philip Wenzel, Siyer Roohani, Eberhard Schulz and Philipp Welschof. Their work appears in journals such as BMC Pharmacology and Toxicology, Brain Research, PLoS ONE, Redox Biology and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.